AllianceBernstein’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $295M | Sell |
|
|||||
|
2025
Q2 | $308M | Sell |
|
|||||
|
2025
Q1 | $387M | Sell |
|
|||||
|
2024
Q4 | $444M | Buy |
|
|||||
|
2024
Q3 | $609M | Sell |
|
|||||
|
2024
Q2 | $731M | Sell |
|
|||||
|
2024
Q1 | $709M | Sell |
|
|||||
|
2023
Q4 | $654M | Buy |
|
|||||
|
2023
Q3 | $570M | Buy |
|
|||||
|
2023
Q2 | $494M | Buy |
|
|||||
|
2023
Q1 | $504M | Buy |
|
|||||
|
2022
Q4 | $437M | Sell |
|
|||||
|
2022
Q3 | $450M | Sell |
|
|||||
|
2022
Q2 | $387M | Buy |
|
|||||
|
2022
Q1 | $404M | Buy |
|
|||||
|
2021
Q4 | $360M | Buy |
|
|||||
|
2021
Q3 | $304M | Sell |
|
|||||
|
2021
Q2 | $492M | Sell |
|
|||||
|
2021
Q1 | $983M | Buy |
|
|||||
|
2020
Q4 | $852M | Buy |
|
|||||
|
2020
Q3 | $870M | Buy |
|
|||||
|
2020
Q2 | $962M | Sell |
|
|||||
|
2020
Q1 | $891M | Sell |
|
|||||
|
2019
Q4 | $733M | Sell |
|
|||||
|
2019
Q3 | $589M | Buy |
|
|||||
|
2019
Q2 | $478M | Buy |
|
|||||
|
2019
Q1 | $474M | Sell |
|
|||||
|
2018
Q4 | $470M | Buy |
|
|||||
|
2018
Q3 | $414M | Buy |
|
|||||
|
2018
Q2 | $260M | Buy |
|
|||||
|
2018
Q1 | $75.9M | Sell |
|
|||||
|
2017
Q4 | $86.9M | Buy |
|
|||||
|
2017
Q3 | $98.3M | Sell |
|
|||||
|
2017
Q2 | $115M | Buy |
|
|||||
|
2017
Q1 | $90.7M | Buy |
|
|||||
|
2016
Q4 | $82.3M | Sell |
|
|||||
|
2016
Q3 | $97.4M | Sell |
|
|||||
|
2016
Q2 | $85.6M | Sell |
|
|||||
|
2016
Q1 | $88.9M | Buy |
|
|||||
|
2015
Q4 | $106M | Buy |
|
|||||
|
2015
Q3 | $69.8M | Buy |
|
|||||
|
2015
Q2 | $76M | Buy |
|
|||||
|
2015
Q1 | $66.6M | Sell |
|
|||||
|
2014
Q4 | $61.5M | Buy |
|
|||||
|
2014
Q3 | $54M | Sell |
|
|||||
|
2014
Q2 | $43.8M | Sell |
|
|||||
|
2014
Q1 | $50.5M | Buy |
|
|||||
|
2013
Q4 | $45.5M | Buy |
|
|||||
|
2013
Q3 | $51.4M | Sell |
|
|||||
|
2013
Q2 | $37.2M | Buy |
|